Majid Afshar1,2,3, Erum Arain1, Chen Ye1, Emily Gilbert1, Meng Xie4, Josh Lee1, Matthew M Churpek5, Ramon Durazo-Arvizu2,3, Talar Markossian2,3, Cara Joyce2,3. 1. Department of Medicine, Loyola University Medical Center, Maywood, IL. 2. Department of Public Health Sciences, Loyola University, Maywood, IL. 3. Center for Health Outcomes and Informatics Research, Heath Sciences Research Campus, Loyola University, Maywood, IL. 4. Department of Applied Statistics, Loyola University, Chicago, IL. 5. Department of Medicine, The University of Chicago, Chicago, IL.
Abstract
OBJECTIVES: Assess patient outcomes in patients with suspected infection and the cost-effectiveness of implementing a quality improvement program. DESIGN, SETTING, AND PARTICIPANTS: We conducted an observational single-center study of 13,877 adults with suspected infection between March 1, 2014, and July 31, 2017. The 18-month period before and after the effective date for mandated reporting of the sepsis bundle was examined. The Sequential Organ Failure Assessment score and culture and antibiotic orders were used to identify patients meeting Sepsis-3 criteria from the electronic health record. INTERVENTIONS: The following interventions were performed as follows: 1) multidisciplinary sepsis committee with sepsis coordinator and data abstractor; 2) education campaign; 3) electronic health record tools; and 4) a Modified Early Warning System. MAIN OUTCOMES AND MEASURES: Primary health outcomes were in-hospital death and length of stay. The incremental cost-effectiveness ratio was calculated and the empirical 95% CI for the incremental cost-effectiveness ratio was estimated from 5,000 bootstrap samples. RESULTS: In multivariable analysis, the odds ratio for in-hospital death in the post- versus pre-implementation periods was 0.70 (95% CI, 0.57-0.86) in those with suspected infection, and the hazard ratio for time to discharge was 1.25 (95% CI, 1.20-1.29). Similarly, a decrease in the odds for in-hospital death and an increase in the speed to discharge was observed for the subset that met Sepsis-3 criteria. The program was cost saving in patients with suspected infection (-$272,645.7; 95% CI, -$757,970.3 to -$79,667.7). Cost savings were also observed in the Sepsis-3 group. CONCLUSIONS AND RELEVANCE: Our health system's program designed to adhere to the sepsis bundle metrics led to decreased mortality and length of stay in a cost-effective manner in a much larger catchment than just the cohort meeting the Centers for Medicare and Medicaid Services measures. Our single-center model of interventions may serve as a practice-based benchmark for hospitalized patients with suspected infection.
OBJECTIVES: Assess patient outcomes in patients with suspected infection and the cost-effectiveness of implementing a quality improvement program. DESIGN, SETTING, AND PARTICIPANTS: We conducted an observational single-center study of 13,877 adults with suspected infection between March 1, 2014, and July 31, 2017. The 18-month period before and after the effective date for mandated reporting of the sepsis bundle was examined. The Sequential Organ Failure Assessment score and culture and antibiotic orders were used to identify patients meeting Sepsis-3 criteria from the electronic health record. INTERVENTIONS: The following interventions were performed as follows: 1) multidisciplinary sepsis committee with sepsis coordinator and data abstractor; 2) education campaign; 3) electronic health record tools; and 4) a Modified Early Warning System. MAIN OUTCOMES AND MEASURES: Primary health outcomes were in-hospital death and length of stay. The incremental cost-effectiveness ratio was calculated and the empirical 95% CI for the incremental cost-effectiveness ratio was estimated from 5,000 bootstrap samples. RESULTS: In multivariable analysis, the odds ratio for in-hospital death in the post- versus pre-implementation periods was 0.70 (95% CI, 0.57-0.86) in those with suspected infection, and the hazard ratio for time to discharge was 1.25 (95% CI, 1.20-1.29). Similarly, a decrease in the odds for in-hospital death and an increase in the speed to discharge was observed for the subset that met Sepsis-3 criteria. The program was cost saving in patients with suspected infection (-$272,645.7; 95% CI, -$757,970.3 to -$79,667.7). Cost savings were also observed in the Sepsis-3 group. CONCLUSIONS AND RELEVANCE: Our health system's program designed to adhere to the sepsis bundle metrics led to decreased mortality and length of stay in a cost-effective manner in a much larger catchment than just the cohort meeting the Centers for Medicare and Medicaid Services measures. Our single-center model of interventions may serve as a practice-based benchmark for hospitalized patients with suspected infection.
Authors: Christopher W Seymour; Foster Gesten; Hallie C Prescott; Marcus E Friedrich; Theodore J Iwashyna; Gary S Phillips; Stanley Lemeshow; Tiffany Osborn; Kathleen M Terry; Mitchell M Levy Journal: N Engl J Med Date: 2017-05-21 Impact factor: 91.245
Authors: Edward J Septimus; Craig M Coopersmith; Jessica Whittle; Caleb P Hale; Neil O Fishman; Thomas J Kim Journal: Clin Infect Dis Date: 2017-10-16 Impact factor: 9.079
Authors: Robert A Raschke; Robert H Groves; Hargobind S Khurana; Nidhi Nikhanj; Ethel Utter; Didi Hartling; Brenda Stoffer; Kristina Nunn; Shona Tryon; Michelle Bruner; Maria Calleja; Steven C Curry Journal: BMJ Open Qual Date: 2017-10-21
Authors: Christopher W Seymour; Vincent X Liu; Emily B Brant; Jason N Kennedy; Andrew J King; Lawrence D Gerstley; Pranita Mishra; David Schlessinger; James Shalaby; Gabriel J Escobar; Derek C Angus Journal: NPJ Digit Med Date: 2022-04-04
Authors: Ian J Barbash; Billie S Davis; Jonathan G Yabes; Chris W Seymour; Derek C Angus; Jeremy M Kahn Journal: Ann Intern Med Date: 2021-04-20 Impact factor: 25.391
Authors: Edmond C K Li; Sela Grays; Abner Tagoola; Clare Komugisha; Annette Mary Nabweteme; J Mark Ansermino; Craig Mitton; Niranjan Kissoon; Asif R Khowaja Journal: PLoS One Date: 2021-11-17 Impact factor: 3.240
Authors: Khalia Ackermann; Jannah Baker; Malcolm Green; Mary Fullick; Hilal Varinli; Johanna Westbrook; Ling Li Journal: J Med Internet Res Date: 2022-02-23 Impact factor: 7.076
Authors: Asif Raza Khowaja; Alexander J Willms; Christina Krause; Sarah Carriere; Ben Ridout; Colleen Kennedy; Eric Young; Craig Mitton; Niranjan Kissoon; David D Sweet Journal: Crit Care Med Date: 2022-04-01 Impact factor: 9.296
Authors: Donald S Bourne; Billie S Davis; Kristin H Gigli; Chung-Chou H Chang; Jonathan G Yabes; Grant R Martsolf; Jeremy M Kahn Journal: Crit Care Med Date: 2020-10 Impact factor: 9.296